Liposomal Cisplatin in Treating Patients With Recurrent Ovarian Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of liposomal cisplatin in treating
patients who have recurrent ovarian cancer.
Phase:
Phase 2
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health